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Abstract Proteolytic destruction of cyclins is a fundamental
process for cell division. At the end of mitosis, degradation of
mitotic cyclins results in the inactivation of cyclin-dependent
kinases. Cyclin proteolysis is triggered by the anaphase-promot-
ing complex/cyclosome (APC/C), a multi-subunit complex
which contains ubiquitin ligase activity. Recent data in yeast
demonstrated that a partial degradation of the mitotic cyclin
Clb2, mediated by APC/C and its activator protein Cdc20, is
essential and su⁄cient for the mitotic exit. Remarkably, a com-
plete inactivation of cyclin-dependent kinases seems to be not
essential. This review discusses recent novel insights into cyclin
destruction and its implications for the mitotic exit.
' 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Cyclin degradation: a historical overview
Twenty years have passed now since Tim Hunt and his
coworkers set a milestone in cell cycle research. When study-
ing protein synthesis in sea urchin embryos, they discovered a
novel protein which is destroyed every time cells divide [1].
Due to its cyclic appearance this protein was termed cyclin. In
the last two decades, cyclins have been identi¢ed in all eukary-
otes and their functions as regulatory subunits of cyclin-de-
pendent kinases (CDKs) have been intensively studied.
But why do cells need to get rid of cyclins and how do they
do this? The former of these questions was ¢rst addressed by
Marc Kirschner’s lab in the late 1980s. They demonstrated the
importance of cyclin destruction by constructing a truncated
version of cyclin B [2]. When the N-terminal region of sea
urchin cyclin B was deleted, these cyclins could not be de-
graded and CDKs remained active. As a consequence, cells
were arrested in mitosis. Subsequent experiments in yeast re-
vealed that high amounts of a stabilised version of the mitotic
cyclin Clb2 speci¢cally blocked very late events in mitosis, the
mitotic exit [3]. These cells arrested with chromosomes segre-
gated to opposite poles and with elongated mitotic spindles.
These results demonstrated that the inactivation of CDKs,
mediated by destruction of the regulatory cyclin subunit, is
needed for spindle disassembly, cytokinesis and the transition
into G1 phase.
The early 1990s then brought the breakthrough in identify-
ing the mechanism of cyclin destruction and of the cellular
machinery which triggers this process. Glotzer et al. [4] found
that cyclin degradation was dependent on a speci¢c sequence
element in the N-terminal region, the degenerate but highly
conserved motif RxxLxxxxN, termed the destruction box.
They further showed that cyclin B is degraded by the ubiq-
uitin pathway. The ubiquitination reaction involves multiple
steps and ¢nally results in the formation of ubiquitin chains
on the target protein. These modi¢ed proteins are then recog-
nised and degraded by the 26S proteasome.
The next key step in understanding cyclin destruction was
the identi¢cation of the anaphase-promoting complex/cyclo-
some (APC/C), an 11-subunit complex which contains ubiq-
uitin ligase activity [5^9]. Ubiquitin ligases catalyse the last
step in the ubiquitination reaction, the transfer of ubiquitin
to the target proteins. APC/C is now known as a central
regulator of mitosis (reviewed in [10,11]). In addition to cy-
clins, it also triggers destruction of many other proteins, such
as securins, polo kinases and spindle-associated proteins. Se-
curin proteolysis is essential for sister chromatid separation
and thus, securin and mitotic cyclins are now known to be
the main targets of APC/C in mitosis.
But how does this ubiquitin ligase trigger proteolysis of the
right protein at the right time? A clue to an answer was the
discovery of two proteins, known as Cdc20 and Cdh1 [12,13].
Both proteins contain WD40 repeats and are, like APC/C,
highly conserved in eukaryotes (Table 1). The association of
APC/C with either Cdc20 or Cdh1 is essential for its activity.
It now appears that these WD40 proteins bind directly to
target proteins and recruit them to the APC/C core complex
[14^17]. Importantly, Cdc20 and Cdh1 bind APC/C in a se-
quential manner during mitosis. At the metaphase/anaphase
transition, APC/CCdc20 is activated and triggers securin degra-
dation, thereby allowing separases to become active and dis-
solve the cohesion between sister chromatids [18]. Cdh1 binds
APC/C in telophase and participates in the destruction of
mitotic cyclins. APC/CCdh1 remains active in the subsequent
G1 phase. The temporal control of APC/C activation is
mainly achieved by phosphorylation of Cdh1, thereby pre-
venting its association with APC/C until telophase (Fig. 1).
Furthermore, both complexes are regulated by spindle check-
points [11,19]. The spindle assembly checkpoint controls APC/
CCdc20 activity, whereas a spindle orientation checkpoint reg-
ulates the activity of Cdc14 phosphatase, which promotes
Cdh1 dephosphorylation and APC/CCdh1 complex formation.
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2. Job sharing for cyclin destruction by Cdc20 and Cdh1
The initial characterisation of Cdc20 and Cdh1 in budding
yeast provoked a simple model for substrate recognition. It
was proposed that Cdc20 recognises securin and thereby pro-
motes the onset of anaphase, whereas Cdh1 recruits cyclins
and triggers the mitotic exit [12,13]. However, subsequent
¢ndings revealed that Cdc20 is also needed for the exit from
mitosis. A deletion of yeast securin PDS1 suppressed the de-
fect of cdc20 mutants at the metaphase to anaphase transition,
but these cells now arrested with elongated spindles indicating
that they failed to exit mitosis [20]. These results implied that
Cdc20 is required for degradation of additional target pro-
teins. A genetic screening revealed that a deletion of Clb5, a
B-type cyclin known to be important for S phase, suppressed
the telophase arrest and lethality of cdc20v pds1v cells [21].
This was the ¢rst hint that Cdc20 participates in cyclin pro-
teolysis in budding yeast.
Are then mitotic cyclins speci¢cally recognised by Cdh1?
Further studies clearly contradicted this assumption, by show-
ing that these cyclins get degraded during anaphase indepen-
dently of Cdh1. Clb2, the major yeast mitotic cyclin, was
partially destroyed in a destruction box-dependent manner,
as soon as APC/CCdc20 was activated at the metaphase/ana-
phase transition [22,23]. In parallel to Clb2, Cdk1 activity also
dropped to a lower level. It was estimated that approximately
50% of Clb2 normally present in metaphase cells gets de-
graded in a Cdc20-dependent manner [23]. Intriguingly, a sec-
ond fraction of Clb2 remained stable during anaphase sug-
gesting that it was protected from APC/CCdc20. Proteolysis of
this Clb2 fraction was dependent on APC/CCdh1 activation in
telophase. The conclusion from these results was that Cdc20
initiates destruction of mitotic cyclins, but it can only partially
ful¢l this task. Cdh1 is required to take over Cdc20’s job to
¢nally complete Clb2 destruction. Thus, Clb2 is degraded in
mitosis by a division of labour between Cdc20 and Cdh1, but
until recently, it was unknown whose job is relevant for the
mitotic exit.
3. An essential role of Cdc20: destruction of Clb2
Initial results suggested that Clb5 is the only important
target of APC/CCdc20 among the cyclins, but a recent paper
by Wa«sch and Cross [24] came to completely new conclusions.
They showed that Cdc20 performs a crucial task by targeting
Clb2 for degradation, by analysing Clb2 and Clb5 pro-
teins lacking their cyclin destruction boxes, Clb2vDB and
Clb5vDB. CLB2vDB expressed from its own promoter e⁄-
Table 1
Cdc20 and Cdh1 family members in di¡erent eukaryotes
Family Name Organism Substrate recognition motif Period of APC/C activation/
substrate recruitment
Cdc20 family Cdc20 Saccharomyces cerevisiae D box Anaphase
Slp1 Schizosaccharomyces pombe
Fzy Drosophila melanogaster
hCDC20/
p55CDC20
Homo sapiens
Cdh1 family Cdh1/Hct1 Saccharomyces cerevisiae D box+KEN box Telophase+G1 phase
Ste9/Srw1 Schizosaccharomyces pombe
Fzr Drosophila melanogaster
hCDH1 Homo sapiens
Fig. 1. Regulation of APC/CCdc20 and APC/CCdh1. A: APC/CCdc20 activation in metaphase requires phosphorylation of speci¢c APC/C subunits
by cyclin-dependent kinase 1 (Cdk1) and polo kinase. Kinetochores not attached to the mitotic spindle (or not under tension) activate the spin-
dle checkpoint. Two spindle checkpoint proteins, Mad2 and BubR1, bind Cdc20 and inhibit its activity until all kinetochores achieve a bipolar
attachment [11]. B: Cdh1 is phosphorylated by Cdk1 and thereby its binding to APC/C is prevented. In late anaphase/telophase, Cdc14 dephos-
phorylates Cdh1 and allows APC/CCdh1 complex formation and activation. Cdc14 activation requires a group of proteins termed the ‘mitotic
exit network’ (MEN), which triggers the release of Cdc14 from the nucleolus. The MEN is controlled by a spindle checkpoint monitoring the
orientation of the mitotic spindle (for review see [31]).
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ciently blocked the mitotic exit demonstrating that Clb2 deg-
radation is essential for this cell cycle transition (Fig. 2). In
contrast, CLB5vDB expressed from either its own or a strong
inducible promoter failed to arrest cells in telophase [24,25].
How do these results ¢t with the viability of cdc20v pds1v
clb5v cells, which suggested that Clb5 is an essential target of
APC/CCdc20 [21]? A possible explanation was provided by
Surana and co-workers [26]. In agreement with similar data
from David Pellman’s lab [27], they showed that Clb5-asso-
ciated Cdk1 participates in turning o¡ APC/CCdh1 in early S
phase. In clb5v strains, APC/CCdh1 did not become completely
inactivated, as manifested by less phosphorylated forms of
Cdh1. As a consequence, Clb2 did not accumulate to normal
levels. This may indicate that Cdc20 is not essential for cyclin
destruction in clb5v strains because APC/CCdh1 is abnormally
active in these cells. Thus, a major role of Clb5 is likely APC/
CCdh1 inactivation in early S phase rather than controlling the
mitotic exit.
4. Mitotic exit without Cdk1 inactivation
The results of Wa«sch and Cross [24] imply that a partial
Cdk1 inactivation caused by APC/CCdc20-mediated Clb2 pro-
teolysis is essential and su⁄cient for most aspects of the mi-
totic exit. In contrast, proteolysis of the remaining Clb2 pro-
tein by APC/CCdh1 and complete Cdk1 inactivation are
dispensable. It was already known that cells lacking Cdh1
are viable, because yeast cells have a redundant mechanism
for Cdk1 inactivation [12]. The Cdk1 inhibitor protein Sic1
accumulates in late mitosis and contributes to kinase inacti-
vation [28]. Thus, in the absence of Cdh1, Sic1 alone is su⁄-
cient to turn o¡ Cdk1. Cells lacking both Cdh1 and Sic1 were
found to be non-viable and it was thought that this is due to a
failure to inactivate Cdk1 in late mitosis [12]. These double
mutants, kept alive by a GAL-SIC1 construct, were now re-
investigated [24]. Intriguingly, cdh1v sic1v mutants were able
to exit from mitosis, albeit with a slight delay and some ab-
normal morphologies (Fig. 2). Kinase assays con¢rmed that
this cell cycle transition occurred in the presence of active
Cdk1/Clb2 kinase suggesting that a complete inactivation of
this kinase is not essential for the mitotic exit.
The persisting Cdk1/Clb2 activity in cdh1v sic1v cells indi-
cates that no other factor is able to replace Cdh1 and Sic1 in
the inactivation of this kinase. Cdc6, a factor required for
DNA replication, was earlier shown to contribute to Cdk1
inhibition in late mitosis [29]. One possibility could be that
Cdc6 inhibits Cdk1 only locally, perhaps at origins of repli-
cation. Such a model would be consistent with the ¢ndings
that cdh1v sic1v mutants are able to re-initiate DNA replica-
tion in the presence of partially active Cdk1 [24]. Since this
process is dependent on low Cdk1 activity [30], a localised
kinase inactivation at origins of DNA replication may allow
the reloading of pre-replicative complexes.
5. A new role of Cdc14 in the mitotic exit?
The mitotic exit of cdh1v sic1v mutants has also posed new
questions about Cdc14, a phosphatase essential for the exit
from mitosis. Cdc14 is kept inactive in the nucleolus for most
of the cell cycle and is released during anaphase [31]. It was
Fig. 2. Clb2 degradation and the exit from mitosis in budding yeast. In wild-type yeast cells, Clb2 is degraded in a biphasic manner: in early
anaphase by APC/CCdc20 and in telophase by APC/CCdh1[22,23]. Cyclin degradation results in Cdk1 inactivation and mitotic exit. Clb2 with a
destruction box deletion (Clb2vDB) is stable throughout mitosis and blocks the transition into G1 phase [24]. In cells lacking both Cdh1 and
Sic1 (cdh1v sic1v), a fraction of Clb2 is degraded by APC/CCdc20. The second fraction of Clb2 is not degraded and Cdk1 remains partially ac-
tive, but nevertheless, these cells exit mitosis. In contrast, APC/CCdc20-mediated degradation of Clb2 is not su⁄cient for the mitotic exit in
cdc14 mutants, indicating that Cdc14 has essential targets other than Cdh1 and Sic1.
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thought that Cdc14’s key role is to inactivate cyclin-dependent
kinases, by dephosphorylating Cdh1 and Sic1 [32,33], but the
dispensability of these Cdc14 targets for the mitotic exit en-
forces a modi¢cation of this model. Unlike cdh1v sic1v dele-
tions strains, cdc14 mutants are blocked in telophase at their
restrictive temperature (Fig. 2), suggesting that Cdc14 has at
least one additional and essential target. Further known sub-
strates of Cdc14 phosphatase are Cdc15 [34] and Bfa1 [35],
two factors of the mitotic exit network, and Swi5 [32], a tran-
scription factor whose dephosphorylation allows its nuclear
entry. It remains to be shown whether the essential role of
Cdc14 in the mitotic exit is dephosphorylation of one of these
substrates or of a new one.
The persistent telophase arrest caused by the non-destruc-
tible Clb2vDB protein further implies that a partial Clb2 deg-
radation is required for Cdc14 function. It is known that
highly active Cdk1 does not inhibit the release of Cdc14 phos-
phatase from the nucleolus, but rather antagonises Cdc14 ac-
tivity [36]. Cdc14’s capacity to dephosphorylate its targets
appears to be insu⁄cient in the presence of a highly active
kinase. It seems that Cdc14 phosphatase can only win the
competition against Cdk1/Clb2, if this kinase is partially in-
activated by Cdc20-mediated Clb2 destruction. This depen-
dence of Cdc14 on partial Cdk1 inactivation ensures that
Cdc20 function always precedes Cdc14 activation and thereby
may help to coordinate sister chromatid separation with the
mitotic exit.
6. Conserved roles of Cdc20 and Cdh1 in cyclin destruction
The recent new data on cyclin destruction in yeast imply
that the roles of Cdc20 and Cdh1 are much more evolutio-
narily conserved than initially thought. In most eukaryotes,
Cdc20 is obviously the key factor for cyclin degradation dur-
ing mitosis, whereas Cdh1 is dispensable for mitosis, but im-
portant during G1 phase.
The involvement of mammalian Cdc20 in cyclin proteolysis
was ¢rst demonstrated with in vitro experiments showing that
APC/CCdc20 is able to trigger ubiquitination of cyclin B [37,38].
Strong evidence for an in vivo role of Cdc20 in this process was
just recently provided [39]. Human cells transfected with a
modi¢ed cyclin B, containing a substitution of the destruction
box by a KEN box, arrested in telophase, although this modi-
¢ed cyclin was shown to be a substrate of Cdh1. Since Cdh1
cannot ful¢l Cdc20’s function, human Cdc20 is obviously es-
sential for cyclin B degradation in mitosis.
Cyclin B degradation is also triggered by APC/CCdc20 in
Xenopus and Drosophila embryos. Embryonic cell cycles are
composed of alternating S and M phases lacking intervening
gap phases. Importantly, CDH1 is not expressed in early em-
bryonic cells of these organisms [40,41]. A recent paper dem-
onstrated that the Drosophila Cdh1 homologue Fzr is indeed
absent and not required for mitosis [42]. By excluding the
possibility that small amounts of maternally derived Fzr/
Cdh1 contribute to the mitotic exit, the authors showed that
the Cdc20 homologue Fzy alone is su⁄cient for the comple-
tion of mitosis in Drosophila embryos and that Fzr/Cdh1 is
needed exclusively for the subsequent G1 phase.
This function of Cdh1 in G1 phase is obviously also highly
conserved in eukaryotes. Yeast cells and Drosophila embryos
depleted of Cdh1 fail to arrest the cell cycle in G1 phase and
ultimately initiate DNA replication [12,40,43]. A primary
function of Cdh1 in G1 cells is probably to inhibit abnormal
cyclin accumulation and CDK activation, thereby preventing
an unscheduled entry into S phase. Cdh1 is also responsible
for degradation of non-cyclin proteins, such as polo kinase,
spindle-associated proteins and kinesins [11]. The viability of
yeast cdh1v mutants implies that proteolysis of none of these
substrates is essential, but their removal is probably important
for a proper coordination of events in the subsequent cell
cycle. APC/CCdh1 is also expressed during G1 and G0 in mam-
malians cells, as well as in terminally di¡erentiated cells such
as neurones [44,45]. How Cdh1 regulates di¡erentiation is still
unknown, but there is now increasing evidence that APC/
CCdh1 has non-cell cycle functions, such as the regulation of
transforming growth factor-L signalling [10,11].
7. Spatial and temporal control of cyclin B degradation in
Drosophila
A biphasic degradation of mitotic cyclins has also been
observed in organisms other than yeast. In Drosophila cells,
proteolysis of cyclin B initiates at centrosomes and then
spreads along the mitotic spindle towards the spindle equator
[46]. Remarkably, in Drosophila mutants in which centro-
somes are detached from the mitotic spindle, cyclin B disap-
peared from centrosomes, but not from the spindle [47]. Cy-
toplasmic cyclin B was degraded slightly later than spindle-
associated cyclins. Thus, cyclin B is degraded in two waves,
¢rst on spindles and then in the cytoplasm. Real-time studies
in living human cells also demonstrated temporally and spa-
tially separable phases of cyclin B destruction [48]. As soon as
the last chromosome aligned on the metaphase plate, cyclin B
was ¢rst eliminated from spindle poles and chromosomes and
only later from other regions of the cell.
Jordan Ra¡ and colleagues [49] recently analysed the roles
of Fzy/Cdc20 and Fzr/Cdh1 in the spatial and temporal de-
struction of cyclin B in Drosophila embryos. They found that
both green £uorescent protein-tagged Fzy/Cdc20 and Fzr/
Cdh1 proteins were associated with spindles in vivo and
bound microtubules in vitro. In living Drosophila embryos,
Fzy/Cdc20 localised predominantly at centrosomes, kineto-
chores and on spindles in early mitosis. Fzr/Cdh1 was found
at centrosomes throughout the cell cycle. They then moni-
tored cyclin B destruction in living early, syncytial embryos,
which lack detectable Fzr/Cdh1, and in cellularised embryos,
which contain normal levels of Fzr/Cdh1. Intriguingly, only
spindle-associated cyclin B was degraded at the end of mitosis
in syncytial embryos. Levels of cytoplasmic cyclin B remained
unchanged suggesting that Fzy/Cdc20 triggers destruction of
cyclin B only on spindles. In cellularised embryos cyclin B was
degraded throughout the cell.
These ¢ndings with living embryos are consistent with ear-
lier data showing that cyclin B is only partially degraded at
the end of mitosis in syncytial embryos [50]. Furthermore, it
was shown that cyclin-dependent kinase Cdk1 was only lo-
cally inactivated near the centrosomes, but remained active in
other parts of the embryo [51]. It appears that cyclin B deg-
radation on mitotic spindles, mediated by Fzy/Cdc20, and
localised Cdk1 inactivation is su⁄cient for the mitotic exit.
This function of Fzy/Cdc20 is essential, because a modi¢ed
cyclin B lacking a functional destruction box was not de-
graded on spindles in syncytial embryos and blocked cells in
mitosis [49].
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Ra¡ et al. [49] proposed the following model for the bipha-
sic degradation of cyclin B: Fzy/Cdc20 catalyses destruction
of cyclin B exclusively on mitotic spindles and this localised
inactivation of Cdk1 allows Fzr/Cdh1 activation at centro-
somes. Cdh1/Fzr then spreads throughout the cell and triggers
proteolysis of the remaining cyclin B. How Fzy/Cdc20 activity
is restricted to the spindle is unknown, but it was proposed
that only the pool of Fzy/Cdc20 which has been loaded onto
the spindles via kinetochores is competent to degrade cyclin B.
8. Conclusions
It remains to be shown whether yeast Cdc20 and Cdh1 are
localised in a similar manner as their homologues in Droso-
phila and whether the biphasic Clb2 degradation is due to a
restriction of Cdc20 function to spindles. However, the last
few months have provided some unexpected similarities in
cyclin destruction among eukaryotes. In both yeast and Dro-
sophila, mitotic cyclins are degraded in two steps, and in both
organisms, only the ¢rst, Cdc20-dependent step is essential for
the exit from mitosis. The mitotic exit of Drosophila syncytial
embryos and of yeast cdh1v sic1v mutants suggests that com-
plete Cdk1 inactivation is dispensable for this cell cycle tran-
sition. It will be an interesting task to ¢nd out how speci¢cally
Cdk1 associated with the Cdc20-sensitive fraction of cyclins
a¡ects the exit from mitosis.
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